Therapeutics News and Research

RSS

Researchers shed light on link between cholera outbreaks affecting African and American continents

Researchers at the Institut Pasteur and the Wellcome Trust Sanger Institute, in collaboration with several other international institutions, recently published two studies tracing the history of cholera outbreaks in Africa, Latin America and the Caribbean from the last 60 years.

13 Nov 2017

Epigenetic editing in healthy breast cells can set off chain reaction for tumor initiation

Changing the epigenetic code of a single gene is enough to cause a healthy breast cell to begin a chain reaction and become abnormal, according to research by Queen Mary University of London.

13 Nov 2017

Vaccines in the Aging Population

The World Health Organisation marked World Pneumonia Day on November 12th to promote interventions to protect against, prevent and treat pneumonia. The condition is a worldwide killer affecting people of all ages, however the ‘aging population’ is at an increased risk.

From Pfizer, Inc. 13 Nov 2017

Scientists identify new genes needed by Streptococcus pyogenes to grow in human saliva

Scientific and veterinary research charity, the Animal Health Trust, in partnership with world-leading scientists at the Houston Methodist Research Institute, have identified new genes linked to how, Streptococcus pyogenes, an important cause of human disease, survives in people.

13 Nov 2017

Milestone study could impact standard guidelines for stroke treatment

Standard guidelines for stroke treatment currently recommend clot removal only within six hours of stroke onset. But a milestone study with results published today in the New England Journal of Medicine shows that clot removal up to 24 hours after stroke led to significantly reduced disability for properly selected patients.

12 Nov 2017

New gene therapy for blindness may soon be reality

Patients who had lost their sight to an inherited retinal disease could see well enough to navigate a maze after being treated with a new gene therapy, according to research presented today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology.

10 Nov 2017

UCR researchers elucidate how blood clots shrink

Blood clotting is the "Jekyll and Hyde" of biological processes. It's a lifesaver when you're bleeding, but gone awry, it causes heart attacks, strokes and other serious medical problems.

10 Nov 2017

KU Leuven researchers unravel how cell division timer works

Human cells use a timer to divide: each cell gets at least 30 minutes to divide its genetic material between the nuclei of two daughter cells.

9 Nov 2017

3D cultured spheroids could drive precision treatment for ovarian cancer

Honeycomb-like arrays of tiny, lab-grown cancers could one day help doctors zero in on individualized treatments for ovarian cancer, an unpredictable disease that kills more than 14,000 women each year in the United States alone.

9 Nov 2017

New gene therapy trial for X-linked myotubular myopathy offers hope to children

Ann & Robert H. Lurie Children's Hospital of Chicago is one of the few centers participating in ASPIRO, an international Phase 1/2 clinical trial of a gene therapy product called AT132 for X-linked myotubular myopathy – a rare disease characterized by severe muscle weakness, breathing difficulty and early death.

8 Nov 2017

Scientists uncover previously unknown mechanism to combat influenza A virus

Just as flu season swings into full gear, researchers from the University of Colorado Boulder and University of Texas at Austin have uncovered a previously unknown mechanism by which the human immune system tries to battle the influenza A virus.

8 Nov 2017

Novel approach could help predict how well patients respond to cancer treatment

A novel approach developed by researchers from the University of Leicester and the MRC Toxicology Unit could help to predict how well patients respond to drugs designed to fight various forms of cancer.

8 Nov 2017

Early intervention may be crucial to successful treatment of Friedreich's ataxia

New research published today in Disease Models & Mechanisms indicates that early intervention should be a key target in the development of new therapeutics for Friedreich's ataxia, as current treatments may be administered too late to target the disease effectively.

8 Nov 2017

SBP researchers identify new protective function for brain protein genetically linked to Alzheimer's

Researchers at Sanford Burnham Prebys Medical Discovery Institute have identified a new protective function for a brain protein genetically linked to Alzheimer's. The findings, published in the Journal of Experimental Medicine, could inform novel treatment strategies.

7 Nov 2017

Texas Biomedical Research Institute tests promising new treatment for HBV infection

Research at the Southwest National Primate Research Center on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus (HBV) infection.

7 Nov 2017

Study reveals role of specific lipids in accelerating or curbing bacterial infection

Lipids appear to play an important role in infections. According to researchers from the University of Maastricht in Maastricht, The Netherlands, and the University of Maryland, Baltimore (UMB) in Baltimore, Md., USA, specific lipids can greatly accelerate bacterial infection.

7 Nov 2017

ORBITA trial on heart stents for stable angina indicates placebo effect potential

A new study conducted by researchers at the Imperial College London suggests that the placebo effect experienced by patients who receive coronary artery stents might be larger than expected, even though stents themselves are life-saving.

6 Nov 2017

Scientists develop potential new antidepressant with unique mechanism of action

A potential new antidepressant and antianxiety treatment with a unique mechanism of action has been developed by scientists at the University of Bath.

6 Nov 2017

Research provides path to possible treatment for Fragile X Syndrome and other types of autism

In Fragile X Syndrome--the leading genetic form of intellectual disability and autism--the effects of a single defective gene ripple through a series of chemical pathways, altering signals between brain cells.

3 Nov 2017

An alternative approach to augmenting the effect of antibiotics in chronic CF lung infections

There are about 77,000 people known to have cystic fibrosis. That's from the various cystic fibrosis registries available globally. The World Health Organization suggests that this number may be low, because there's no reporting on cystic fibrosis from the developing world. The accepted number, at the moment, is about 80,000. That's the one that is used for most of the work that's being done on cystic fibrosis.

From Neem Biotech 3 Nov 2017

Therapeutics News and Research

Researchers shed light on link between cholera outbreaks affecting African and American continents

Epigenetic editing in healthy breast cells can set off chain reaction for tumor initiation

Vaccines in the Aging Population

Scientists identify new genes needed by Streptococcus pyogenes to grow in human saliva

Milestone study could impact standard guidelines for stroke treatment

New gene therapy for blindness may soon be reality

UCR researchers elucidate how blood clots shrink

KU Leuven researchers unravel how cell division timer works

3D cultured spheroids could drive precision treatment for ovarian cancer

New gene therapy trial for X-linked myotubular myopathy offers hope to children

Scientists uncover previously unknown mechanism to combat influenza A virus

Novel approach could help predict how well patients respond to cancer treatment

Early intervention may be crucial to successful treatment of Friedreich's ataxia

SBP researchers identify new protective function for brain protein genetically linked to Alzheimer's

Texas Biomedical Research Institute tests promising new treatment for HBV infection

Study reveals role of specific lipids in accelerating or curbing bacterial infection

ORBITA trial on heart stents for stable angina indicates placebo effect potential

Scientists develop potential new antidepressant with unique mechanism of action

Research provides path to possible treatment for Fragile X Syndrome and other types of autism

An alternative approach to augmenting the effect of antibiotics in chronic CF lung infections

Next-generation therapeutics eBook eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News